To investigate the role of 5-HT in the development of the somatosensory cortex, this amine was depleted in newborn (P-O) rats with a single subcutaneous injection of the toxin 5,7-dihydroxytryptamine (5,7-DHT) and thalamocortical organization was assayed by application of the carbocyanine dye Di-I to the thalamocortical radiations or ventrobasal thalamus, or by staining cortical sections for AChE or cytochrome oxidase (CO). High-performance liquid chromatographic analysis of cortices from animals killed on P-6 or P>60 demonstrated that 5,7-DHT treatment resulted in 65.04 f 12.6% and 72.5 f 1.5% reductions in cortical 5-HT, respectively. Alternate cortices from the brains of animals killed on P-6 processed for 5-HT immunoreactivity demonstrated a complete absence of the vibrissa-related pattern of immunoreactivity and only a small number of coarse immunoreactive axons. The 65% depletion of 5-HT did not alter the somatotopic organization of thalamocortical afferents in animals killed on P-6 or P>60, but it did cause 30.5 f 7.3% and 19.1 f 3.7% reductions in the cross-sectional areas of the patches of thalamocortical afferents corresponding to the long mystacial vibrissae (p < 0.05). These reductions were not associated with significant reductions in either brain or cortical weight or with decreases in the dimensions of the thalamic representation of the vibrissa follicles. These results indicate that 5-HT plays a significant role in the development of the thalamic innervation of the primary somatosensory cortex.
[Key words: 5-HT, barrels, Di-I, immunocytochemistry, AChE, 5,74ihydroxytryptamine]
The dominant view regarding somatosensory cortical development is that it depends primarily upon information from sensory epithelia conveyed to cortex via thalamic axons (e.g., Van der Loos and Dorfl, 1978; Killackey et al., 1990; Woolsey, 1990) . However, considerable attention is now being paid to the possibility that "non-1emniscal" corticipetal projections and elements intrinsic to the cortex may strongly influence this process (Fujimiya et al., 1986; D'Amato et al., 1987; Steindler et al., 1989; Ghosh et al., 1990; Rhoades et al., 1990; Blue et al., 199 1) . Perhaps the most robust "non-1emniscal" marker of cortical organization demonstrated so far is the dense 5-HT immunoreactivity that demarcates the representation of the body surface within S-I of all rodents examined to date (Fujimiya et al., 1986; D'Amato et al., 1987; Rhoades et al., 1990; BennettClarke et al., 199 1) . Serotoninergic axons are among the earliest afferents to the developing cortex (Lidov and Molliver, 1982) and a number of studies (e.g., Lauder and Krebs, 1978; Lauder, 1983) have suggested a variety of roles for 5-HT in neural development. However, the results of two experiments have indicated that perinatal depletion of 5-HT has no long-term effect upon the somatotopic clustering of either thalamocortical axons or lamina IV cells (Daugherty and Haring, 1989; Blue et al., 199 1) . These results might prompt the conclusion that the transient and somatotopically patterned distribution of S-HT within S-I plays no significant role in the development of this cortical area. However, interpretation of the results from these important initial experiments is limited by several potential methodological shortcomings. Blue et al. (199 1) did not quantify the degree to which their manipulation [administration of p-chloroamphetamine (PCA)] depleted 5-HT from the developing cortex, nor did they provide any quantitative information regarding the organization of thalamocortical afferents. The aim of the present study was to extend the work of Blue et al. (199 1) by using 5,7-dihydroxytryptamine to achieve greater depletions of 5-HT from the developing cortex and quantifying the effects of this manipulation upon both cortical amine levels and the organization of thalamocortical afferents.
Materials and Methods
Neonatal administration of 5,7-DHT. Pups (~3 hr of age) were pretreated with desmethylimipramine [DMI, 25 mg/kg delivered intraperitoneally; this drug protects the noradrenergic (NE) fibers from the effects of the 5,7-DHT injection] and injected subcutaneously with 100 mg/kg of 5,7-DHT. Control animals were injected with the same volume of sterile physiological saline.
Assessment of brain and cortical weights. Whole brain and cortical weights were determined for all animals. Immediately after sacrifice [for animals whose brains were used for high performance liquid chromatography (HPLC)] or after perfusion (for all other rats), the brain was weighed. When cortices were dissected from the rest of the brain. these were also weighed.
Assessment of cortical 5-HT depletion. Both immunocytochemistry and HPLC were used to assess the effects ofneonatal 5.7-DHT treatment upon cortical 5-HT concentrations. In all animals that provided anatomical results with respect to the organization of thalamocortical afferents, one hemisphere was used for immunocytochemical or HPLC analysis. Additional animals were employed to correlate HPLC and immunocytochemical results (Table 1) .
Animals in which one hemisphere was used for HPLC (see below) were anesthetized with ether and quickly decapitated, and the brain was removed. The cerebral cortex employed for HPLC was dissected on an ice-cold surface. It was quickly weighed, frozen in dry ice and stored at -70°C until needed. The frozen tissue samples were placed in a cold extraction solution composed of 0.4 N perchloric acid, 3 mM EDTA, and 0.23 mM ascorbic acid. Deoxyepinephrine hydrochloride (DEP) at Figure I . Effect of treatment with 5,7-DHT at birth upon the patterning of 5-HT immunoreactivity in the primary somatosensory cortex. A shows the normal pattern of S-HT-immunoreactive axons in a tangential section through the flattened cortex of a normal rat killed on P-6. B is a similar section showing the lack of such immunoreactivity in a rat that received a subcutaneous injection of 5,7-DHT on P-O and was killed on P-6. The arrows point toward anterior (a) and lateral. FP, forepaw; LJ, lower jaw; T, trunk; VIB, vibrissae. Scale bar, 500 pm. a concentration of 5 @ml was included as an internal standard. To compensate for variations in sample size, the extraction solution was W for 20 sec. The samples were then centrifuged at 20,000 x g for 15 min at 4°C. The supematants were removed and stored in the dark on added to each sample at a concentration of 10 rl/mg sample weight. Each mixture was homogenized in an ice bath with a VirSonic Ultrasonic ice until a 20 ~1 aliquot of each sample was injected onto a Waters 300 Cell Disrupter fitted with a titanium microprobe tip operated at 16 pBondapak C,, (3.9 x 150 mm) column. Detection and quantitation of 5-HT in the column eluent were per- formed with a Waters model 464 electrochemical detector using a glassy carbon electrode at a potential of 600 mV. The output from the detector was plotted and measured using a Water's Baseline 8 10 chromatography workstation. Before injecting the samples, the instrument was equilibrated by running the mobile phase (50 mM NaH,PO,, 50 mg/liter sodium octyl sulfate, 20 mg/liter EDTA, and 15% methanol at pH 4.0) through the column at 1 ml/min for several hours. The instrument was calibrated by running 5-HT standards (l-200 x&ml) through the system to determine the standard curve (ratio of 5-HT peak area to concentration). For detection of norepinephrine (NE), the mobile phase composition was changed to 70 mM NaH,PO,, 200 mg/liter sodium octyl sulfate, 90 mg/liter EDTA, and 6% acetonitrile at pH 4.55. The chromatographic peaks of the samples were quantified by peakarea measurements and compared to the peak-area curve of the standards. To verify the identity of the 5-HT peak, the retention times of the peak found in the samples with the peak given by the standard were compared. In addition, on several occasions reagent 5-HT was added to previously run samples. In these experiments, a single appropriately enlarged peak with a retention time identical to that of the 5-HT from the standard solution was always observed. Similar methods were employed in a small number brains to determine the effects bf neonatal 5,7-DHT administration on the cortical concentration of NE.
Processing of brains for immunocytochemistry followed the procedures described by Rhoades et al. (1990) . In animals also used for HPLC, the portion of the brain used for immunocytochemistry was fixed by immersion in 4% paraformaldehyde for 24 d before processing. Other animals were anesthetized with ether and perfused transcardially with 0.9% saline in 0.1 M sodium phosphate buffer (PBS, pH = 7.4, 2 1°C). This was followed by a fixative consisting of 4.0% paraformaldehyde in the same buffer (4°C). Brains were removed and postfixed for 12-36 hr. Sections (50 Nrn) cut through the flattened cortex were incubated in primary antibody (5-HT INCSTAR, 1: 1500 dilution in phosphate buffer) for 14-20 hr at room temperature, rinsed with phosphate buffer, incubated for 1 hour in goat anti-rabbit IgG diluted 1:200, rinsed again, and incubated in AB complex (Vectastain) diluted 1: 100. Following several rinses, sections were reacted with 0.05% 3,3'-diaminobenzidine (DAB) and 0.0 15% hydrogen peroxide in 0.1 M phosphate buffer. After several rinses in phosphate buffer, sections were plated on gelatin-coated slides, air dried, dehydrated in graded ethanols, cleared with xylene, and coverslipped with Permount.
In a small number of animals, alternate sections were immunostained using a primary antibody generated against dopamine /3-hydroxylase Figure 2 . A shows HPLC chromatograms for 5-HT generated using an electrochemical detector. Profile 2 is for a standard sample spiked with 50 rig/ml of 5-HT, the smaller peak at 4.9 min is DEP, the large peak with an elution time of 6.6 min is 5-HT. Profile 1 is for the biogenic amines present in the S-I cortex of a P-6 rat; note the 5-HT peak at 6.6 min, which corresponds exactly with the standard. B is a bar graph showing the concentrations of 5-HT (mean + SD) in the cortices of rats treated with subcutaneous injections of 5,7-DHT on the day of birth and littermate controls. All animals were killed on P-6. Data from seven different litters are presented along with the averaged results from all litters.
(DPH) (Eugene Tech.) to visualize the noradrenergic terminals in S-I. The DPH antibody was diluted 1: 1000 and all subsequent steps of the immunostaining were as previously described. Labeling thalamocortical a&rents with Di-I. In most brains, thalamocortical fibers were labeled by application of Di-I directly to the thalamic radiations. Brains were postfixed for 2-7 d and the cortex used for anterograde tracing was then dissected and weighed. Di-I (l,l'-dioctadecyl-3,3,3",3'-tetramethylindocarbocyanine perchlorate; Molec- ular Probes) was dissolved in 10% dimethylformamide and painted onto the thalamic radiations. After the deposits were completed, the brains were placed in fixative and warmed in a 37°C oven for 4-6 d and then stored in the dark for 2 weeks to 2 months. Cortices were flattened and cut parallel to the pial surface (50~Frn-thick sections) with a freezing microtome and collected in sodium phosphate buffer. Sections were cleared in iothalmate meglumine (Conray, Mallinckrodt) and then placed on a slide in small pools of 50% dextran (Sigma; molecular weight, 67.9 kDa) and coverslipped.
Cytochrome oxidase (CO) staining in the ventral posteromedial thalamus nucleus (VP&f). Cytochrome oxidase was demonstrated in 50 pm diencephalic sections following the protocol of Wong-Riley (1979) . After the completion of this reaction, sections were rinsed, dehydrated in graded alcohols, cleared in xylene, and coverslipped.
In additional animals, thalamocortical fibers were labeled by placement of Di-I crystals into the ventral posteromedial thalamus. Here, crystals of the tracer were picked up with pipettes (20-30 pm tips) and inserted into the thalamus utilizing a dissecting microscope. These brains were then processed in the manner described above.
Evaluation of long-term consequences of neonatal 5,7-DHT administration on cortical organization. The long-term effects of neonatal 5,7-DHT administration upon the vibrissa representation in the primary somatosensory cortex were evaluated in a manner similar to that described above except that animals survived for at least 60 d after the neonatal 5,7-DHT injection and cortical patches corresponding to the vibrissae were identified by CO histochemistry rather than Di-I or AChE labeling.
Labeling thalamocortical aflerents by acetylcholinesterase (AChE) histochemistry. Histochemistry for AChE was also employed to label the terminals of thalamocortical afferents (Krist, 1979; Robertson et al., 1988) . Cortices fixed in one of the two ways described above were flattened on a freezing microtome and cut into 50 pm sections. Sections were then processed for the demonstration of AChE according to the method of Schlaggar et al. (1993) .
Measurement of central representations of vibrissa follicles. Tissue in which Di-I was used to label thalamocortical fibers was evaluated as follows. Each tangential section in which patches of label corresponding the four most caudal vibrissa follicles in each row were visible was photographed and printed. These patches were selected for measurement because of their relatively large size and because they were heavily labeled in almost every normal and 5,7-DHT-treated animal. The patch areas were measured using a computerized planimeter. The individual 1 is for a standard sample containing 10 @ml of NE; note the single peak at the elution time of 7.12 min. Pmfle 2 is of the biogenic amines present in the S-I cortex of an adult animal. B is a histogram showing the effects of neonatal 5,7-DHT injections in DMI-pretreated rats upon cortical concentrations on NE. Note the lack of effect in rats killed on P-6 or in adulthood.
x 10' minutes who carried out most (>90%) of these measurements was blind as to the treatment of the animal. The largest measurement for each patch in a given cortex was used for analysis. When thalamocortical afferents were labelled by AChE histochemistry, patches were drawn using a microscope equipped with a drawing tube and measured in the manner described above. This approach was also used for measurement of COstained patches in cortex and VPM. For statistical analysis, measurements from all patches in a given structure (cortex or VPM) were averaged so that each animal contributed a single value to the analysis.
In an additional analysis designed to assess the validity of hand-drawing of patch borders, AChE-stained sections from six randomly selected normal and six 5,7-DHT-treated animals were analyzed in the following way. Each section was scanned with a computerized densitometer and the density of staining at the center of the patch representing the C-2 vibrissa was measured and set as a threshold. The computer then used this threshold to establish the boundaries of the vibrissa-related patches. These patches were outlined and analyzed as described above and below. Because of the findings obtained with respect to the size of the patches representing the mystacial vibrissae in the cortex (see Results), the distances between the centers of the patches of thalamocortical afferents was also evaluated. This was accomplished by placing a mark in the center of each of the above-described patches and drawing lines to connect all of the marks. The summed distances of these lines would then provide a relative estimate of the total cortical area devoted to the representation of the long caudal vibrissae.
Results from normal and 5,7-DHT-treated animals were compared by means of independent t tests with p < 0.05 as the accepted level of significance.
Results
Effect of neonatal 5,7-DHT injection on the aminergic innervation of the cerebral cortex A single subcutaneous injection of 5,7-DHT on the day of birth resulted in a nearly 90% depletion of 5-HT in the cerebral cortex. The pattern of 5-HT immunoreactivity in the primary somatosensory cortex of a normal rat killed on P-6 is shown in Figure  1A and that in a P-6 rat that sustained a neonatal 5,7-DHT injection is depicted in Figure 1B . The pattern observed in the normal rat is absent in the 5,7-DHT-treated animal. All of the animals used for the analysis of thalamocortical development in which one hemisphere was employed for immunocytochemistry had reductions in 5-HT immunoreactivity similar to that depicted in Figure 1B .
The results of the HPLC analysis confirmed those obtained with immunocytochemistry: subcutaneous injection of 5,7-DHT on the day of birth resulted in an average reduction (mean f SD) of 85.04 +-12.6% (p < 0.05) in the concentration of 5-HT in the cortices of rats killed on P-6. Figure 2A provides an example of a chromatogram demonstrating our ability to measure 5-HT levels using HPLC and Figure 2B summarizes results from seven litters (all killed on P-6) in which littermates either received 5,7-DHT injections (IV = 36 rats) or vehicle only (N = 20 rats). The effect of 5,7-DHT treatment was reasonably consistent across litters. The maximum reduction in 5-HT for a given litter was 100% (litter 93-103) and the minimum reduction was 6 1% (litter 92-168). Only animals in which the depletion of 5-HT was >85% were included in the analysis of cortical organization.
While neonatal injection of 5,7-DHT significantly reduced the concentration of 5-HT in the developing cortex, it had no significant influence upon the apparent density of fibers recognized by an antibody directed against tyrosine hydroxylase (TH), a marker catecholaminergic axons. Figure 3 shows results from two littermates, one of which received a 5,7-DHT injection on the day of birth. Alternate sections from the two animals were processed for 5-HT or TH immunoreactivity. Treatment with 5,7-DHT resulted in a loss of the clustered 5-HT immunoreactivity (Fig. 3C ), but no appreciable change in the density of THpositive fibers (Fig. 30) .
HPLC analysis (Fig. 4 ) demonstrated no significant changes in the concentration of NE in the cortices of 5,7-DHT-treated rats. Figure 4A shows a chromatogram demonstrating our ability to measure NE, and Figure 4B shows results from one litter of rats (four control and seven 5,7-DHT-treated animals) killed on P-6 and one litter (three control and three 5,7-DHT-treated animals) killed after they reached P-60. Neonatal administration of 5,7-DHT had no significant short-or long-term effects on the concentration of NE in the cerebral cortex. Effect of neonatal 5,7-DHT injection on the thalamic innervation of the primary somatosensory cortex Treatment with 5,7-DHT on the day of birth had no significant effect on the somatotopic patterning of thalamocortical afferents in rats killed on P-6 (Fig. 5) . Thalamocortical fibers labeled with Di-I in both normal and manipulated animals were organized in clusters or patches that corresponded to the distribution of the mystacial vibrissae.
Neonatal treatment with 5,7-DHT did produce a quantitative change in the patterning of thalamocortical afferents. The patches or clusters in the neonatally manipulated rats (Fig. 5B,D) were consistently smaller than those in the normal animals ( Fig.   5A ,C). Figure 6 shows the areas of patches of Di-I-labeled thalamocortical axons measured in three separate litters with all animals killed on P-6. Each pair of bars in each panel provides the mean cross-sectional area (+SD) for the patches of thalamocortical axons corresponding to the four most caudal vibrissae in each row. Note first that the patches of thalamocortical afferents corresponding to ventral row (D and E) vibrissa follicles are larger than those corresponding to more dorsal row follicles (A and B) and that the reduction in patch size in the 5,7-DHT-treated animals is approximately the same for all rows. Overall, neonatal 5,7-DHT treatment resulted in a 33.7 f 4.7% reduction for all patches of thalamocortical afferents corresponding to the large mystacial vibrissa follicles. The average cross-sectional area of the cortical patches representing these follicles in the normal animals was 0.0937 + 0.011 mm*. That for the same patches in the 5,7-DHT-treated animals was 0.0579 + 0.005 mm* (p < 0.05). Patches corresponding to A-row follicles were decreased in area by 38.1%, B-row patches were decreased by 36.9%, C-row patches by 28.02%, D-row patches by 33.2%, and E-row patches by 34.3%. All of these decreases were statistically significant (p < 0.05).
The measurements described in the preceding paragraphs were obtained from animals in which Di-I was applied to the thalamic radiations after the cortex had been dissected from the rest of the brain. It is possible that raphe axons passing into the cortex from its rostra1 pole may have been labeled in these preparations. If this were the case, the reduction in the patch size in the 5,7-DHT-treated animals may have simply reflected the loss of the 5-HT axons that are codistributed with thalamocortical afferents for the first 2 weeks of life. Two control experiments were carried out to address this issue.
In one group of rats (four normal and seven 5,7-DHT-treated animals) killed on P-6, Di-I crystals were placed in the ventrobasal thalamus to label the terminals of thalamocortical fibers (Fig. 7) . The average cross-sectional area for the patches corresponding to the long mystacial vibrissae in the normal rats . Three histograms each representing the areas of patches of thalamocortical axon arbors measured in lamina IV of the cortices of litters of animals that were killed on P-6. Half of the animals in each litter received a subcutaneous injection of 5,7-DHT on the day of birth and the remaining animals were controls. Each bar represents the mean (+SD) for all the patches in a given row for all of the normal or 5,7-DHT-treated animals in a litter. The differences between the results from the normal and experimental animals from each litter are statistically significant (p < 0.05).
was 0.0628 f 0.008 mm* and that for the 5,7-DHT-treated animals was 0.0489 + 0.003 mm2 (p < 0.05).
In a second group of rats (9 normal and 11 5,7-DHT-treated animals), staining for AChE (Fig. 8 ) was employed to label the terminals of thalamocortical axons (Krisst, 1979; Robertson et al., 1988; Schlaggar et al., 1993) . The average size of the cortical patches corresponding to the long mystacial vibrissae in the normal animals was 0.0410 f 0.002 mm2 and that for the 5,7-DHT-treated animals was 0.02899 + 0.002 mm2 (p < 0.05).
The results from these two groups of animals indicate that the reduced area of the patches of Di-I labeling in the 5,7-DHTtreated rats in which tracer was applied to the thalamic radiations was not the result of the "subtraction" or raphe-cortical axons present in the normal animals.
The results obtained with the computer-assisted analysis of AChE-stained sections from normal and 5,7-DHT-treated animals provided results consistent with those described above. The average patch size in the normal animals was 0.043 f 0.01 mm* and that for the 5,7-DHT-treated animals was 0.031 f 0.01 mm2. Thus, the average reduction in patch size for the 5,7-DHT animals was 28%, a value very similar to the 29% obtained in the by-hand measurements.
Efects of neonatal 5,7-DHT treatment on brain and cortical weight
Analysis of brain and cortical weights of the animals that contributed to analysis described immediately above indicated that neonatal 5,7-DHT treatment had no significant effect upon either of these measures (Fig. 9) . The average brain weight (Fig.  9A) for the normal animals (mean f SD) was 0.604 f 0.062 gm and that for the treated rats was 0.589 & 0.070 gm (p > 0.05). The average cortical weight (Fig. 9B) for the normal animals was 0.138 f 0.042 gm and that for the treated rats was 0.140 f 0.038 gm (p > 0.05). It is important to note that all of the 5,7-DHT-treated animals from the litters included in this analysis had significant reductions in the cortical 5-HT (see Fig.  2 ).
Eflects of neonatal 5,7-DHT treatment on the thalamic vibrissa representation
The developing ventrobasal complex is not heavily innervated by 5-HT-containing axons (Fig. 1OC ) and neonatal administration of 5,7-DHT has no substantial effect upon the density of this innervation (Fig. 1OD ). There was also no effect of neonatal 5,7-DHT treatment upon the average cross-sectional area of the CO-reactive patches representing the vibrissa follicles (compare Fig. 1 OA,B) . The average size of the CO-reactive patches corresponding to the four most caudal vibrissa follicles in each row in normal rats killed on P-6 was 0.00569 f 0.0005 mm2 and that for the same follicles in neonatally treated rats killed on P-6 was 0.00543 + 0.0005 mm2 (p > 0.05).
Long-term effects of neonatal 5,7-HT treatment upon the organization of the primary somatosensory cortex
The 5,7-DHT-induced change in cortical organization was maintained into adulthood. We used CO staining to visualize the patches corresponding to the mystacial vibrissae in adult rats (Fig. 1 L&B) . The average cross-sectional area of the cortical patches representing the large mystacial vibrissae in the normal animals was 0.1295 + 0.0 13 1 mm*. That for exactly the same patches in the 5,7-DHT-treated animals was 0.1045 f 0.0122 Figure 7 . Low-power episcopic fluorescence photomicrographs of tangential cortical section from a normal (A) and 5,7-DHT-treated littermate (B) killed on P-6. In each case, Di-I was placed in the ventral posterior thalamus to visualize the thalamocortical axon arbors in laver IV of S-I. Note the differences in the sizes of the Di-I labeled patches in the normal and 57 DHTtreated animals. Scale bar, 500 pm. mm2 (Fig. 11C ). This 19.3% reduction was statistically significant (p < 0.05).
Efects of 5,7-DHT treatment on the area of cortex devoted to the vibrissa representation the mystacial vibrissae and that this occurs without a corresponding shrinkage of the brain or cortex or a reduction in the size of the subcortical representations of the mystacial vibrissa follicles. Analysis of distances between the centers of patches of thalamocortical afferents labeled by staining for AChE or thaAll of the results presented in the preceding subsections indicate lamic application of Di-I (Fig. 12 ) demonstrated further that that 5,7-DHT treatment results in a reduction of the size of the neonatal 5,7-DHT treatment did not significantly reduce the patches of thalamocortical afferents or CO activity representing size of the total cortical area devoted to the representation of A is from a P-6 control, and B is from a littermate that received a 5,7-DHT injection. C is a histogram showing the results of cortical AChE patch measurements taken from two litters killed on P-6. Each bar represents the average for all of the patches measured in either the control or the 5,7-DHT injected animals.
The differences between the treated and untreated animals in each litter were statistically significant (p < 0.05). Scale bar, 500 Ccm.
the long mystacial vibrissae. Importantly, all of the animals included in this analysis were also included in that which showed that neonatal 5,7-DHT treatment reduced the size of the cortical AChE patches corresponding to the vibrissae.
Discussion
The present results indicate that depletion of 5-HT from the developing cortex by administration of 5,7-DHT on the day of birth produces a significant and maintained reduction in the size of the patches that comprise the cortical representation of the long mystacial vibrissae. This decrease occurs without any corresponding changes in the weight of the brain or cortex, in the overall area of the cortex devoted to the vibrissa representation, or in the CO-reactive patches corresponding to the vibrissae in the ventrobasal thalamus.
Technical limitations
Before relating the present results to those of previous studies, it is important to acknowledge several important limitations of this study. First, we were unable to evaluate the effects of 5-HT depletion on the cytoarchitectonic units representing the vibrissae, the barrels. In the rat's somatosensory cortex, these aggregates of cells are much less well defined than in the mouse and we therefore restricted our measurements to patches of thalamocortical afferents in the perinatal animals and CO-stained patches in the adult rats. We did attempt to carry out a parallel series of experiments in mice, but were unable to obtain ~60% depletions of 5-HT in the cortices of these animals with the combination of 5,7-DHT and DMI (see Osterheld-Haas, 1994 , for comparable data). In mice depleted to this extent, somatotopically distributed 5-HT-positive could still be seen in immunostained cortical sections. One puzzling aspect of our results apparent from examination of the data presented in Figure 6 is that there was considerable variability in the size of vibrissa-related patches in animals from different litters. This effect was not significantly related to brain weight (r = 0.11, p > 0.05). One other source of variability that should be acknowledged is the difference in the labeling efficiency of the three methods employed to visualize patches of vibrissa-related thalamocortical afferents in perinatal rats. The patches labeled by application of Di-I to the thalamic radiations were larger than those labeled by injection of Di-I into the thalamus and these were larger than those labeled by staining for AChE. The smaller size of the AChE-stained patches is readily explained by the tissue shrinkage associated with histochemical processing. The larger size of patches labeled by application of Di-I to the thalamic radiations versus those labeled by thalamic injection of the same tracer is most likely due to the more complete labeling that might be expected after very large tracer deposits placed very close to the target analyzed. It is important to note that these differences did not influence our analysis since all comparisons were among cortical patches labeled by the same method.
Relationship of present results to those from previous studies One important aspect of the present results agrees well with the prior findings of Daugherty and Haring (1989) and Blue et al. (199 1) . Results from both ofthose studies and the present report are in agreement in that cortical 5-HT depletion had no effect upon the somatotopic organization of the vibrissa representation in the developing cortex. However, the present results differ from those provided by Daughtery and Haring (1989) in that we observed significant reductions in the cross-sectional areas ofthe patches ofDi-I-labeled thalamocortical fibers (in perinatal rats) and CO reactivity (in adult animals) while Daughtery and Haring (1989) did not report any such change in rats killed at 20 d of age.
One potential source of the difference between the present findings and those of Daughtery and Haring (1989) is the difference in the degree of cortical 5-HT depletion achieved in the two studies. Daughtery and Haring (1989) achieved a 65% loss of 5-HT from cortex at 3 d after their PCA injections, but levels of this amine were reduced by only 25% in adulthood, the time at which all of their evaluations of cortical morphology were carried out. In the present study, the average 5-HT depletion on P-6 was 85.4% and that in adulthood was 72.5%.
Potential mechanisms underlying the effect of 5-HT on the developing cortex There are a number of ways in which neonatal depletion of 5-HT might reduce the size of the patches of thalamocortical afferents corresponding to the mystacial vibrissae. It is possible that 5,7-DHT treatment reduces the number of thalamocortical fibers that contribute to a given cortical patch. We do not believe that this is the case since the size of the CO-reactive patches corresponding to the vibrissae in the thalami of the 5,7-DHTtreated animals were normal. Moreover, preliminary counts of neurons in the ventrobasal complex of one normal and one 5,7-DHT-treated rat, each killed on P-6, indicate that 5,7-DHT treatment did not reduce thalamic cell number (C. A. BennettClarke, unpublished observations).
It is also possible that 5,7-DHT treatment reduced the size of the terminal arbors of individual thalamocortical fibers. This possibility might be viewed as consistent with the results of in vitro studies that have shown that increasing concentrations of 5-HT enhance neuropil formation and synaptic development in the growing cortex (e.g., Chubakov et al., 1986) . The suggestion of a direct positive effect of 5-HT upon axonal growth seems somewhat surprising in view of the work of Rater and his colleagues (Haydon et al., 1984; Haydon et al., 1987; McCobb et al., 1988a,b) . They demonstrated that addition of 5-HT to the culture medium surrounding growing neurites from Helisoma neurons caused an immediate cessation of their elongation. However, it must be noted that the effects of 5-HT in this system were quite specific. 5-HT consistently arrested neurite elongation for identified neurons B 19, P 1, and P5, but not for cells B4 and B5 (McCobb et al., 1988b) . More recently, Goldberg and Rater (1989) showed that depletion of 5-HT in developing Helisoma in vivo by administration of 5,7-DHT also altered the development of B-19. Baker et al. (1993) have also demonstrated that depletion of 5-HT in the snail Achatina fulica results in axonal sprouting by buccal ganglion neurons.
It is also possible that the 5,7-DHT-induced reduction in A shows the brain weights (mean + SD) for animals from many of the litters that provided the data for this study. B shows the cortical weights for several of these animals. There were no statistically significant differences between the results from the normal and 5,7-DHT-treated animals.
5-HT concentration in the developing cortex influenced the size of individual thalamocortical axon arbors indirectly, perhaps by changing the normal operation of activity-dependent processes. There is strong evidence from many portions of the mature nervous system that 5-HT acting at the 5-HT,, receptor has very strong presynaptic inhibitory effects Williams, 1989, 1990a; Wu et al., 1991; Tan and Miletic, 1992; Huang et al., 1993) . Shi et al. (1993) have also shown that 5-HT has presynaptic inhibitory effects in the developing somatosensory cortex and provided additional evidence indicating that these effects are mediated by the 5-HT,, receptor. In addition, Leslie et al. (1992) used autoradiographic techniques to show that 5-HT,, receptors assume a pattern that exactly matches ference with retinotectal activity in "three-eyed" frogs by application of NMDA receptor antagonists disrupted the segregation of axons into eye-specific domains, but that the application of exogenous NMDA actually sharpened boundaries between the tectal regions innervated by one or the other eye and reduced the size and branching of retinotectal axons. Cline and Constantine-Paton (1990) suggested that the smaller size and decreased branching of retinotectal axons in NMDA-treated tecta reflected augmentation of the normal process in which coactive axon branches are selectively stabilized. It seems reasonable to suggest that the same sort of augmentation ofactivity-dependent processes might occur when 5-HT is depleted from the developing cortex. Direct comparison of the present results with those of Constantine-Paton and associates awaits analysis of single thalamocortical axons from 5,7-DHT-treated rats.
The suggestion that the effects of 5,7-DHT upon the development of thalamocortical axons result from removal of SHTmediated presynaptic inhibition and enhancement of activitydependent axonal sorting processes seems difficult to reconcile with observations that direct manipulations of cortical activity have no significant effects upon normal thalamocortical development assessed using methods similar to those employed in this study. Chiaia et al. (1992) showed that blockade of cortical activity with TTX did not reduce the size of the patches of . A and B are low-power bright-field photomicrographs of tangential sections through lamina IV of parietal cortex of one normal adult rat (A) and a littermate that received a subcutaneous injection of 5,7-DHT on the day of birth (B). Cortical aggregates related to vibrissae have been visualized by staining for CO. C shows areas (mean + SD) of CO-stained cortical barrels of normal and 5,7-DHT treated adult rats. The difference between the normal and 5,7-DHT-treated animals was statistically significant (p < 0.05). Scale bar, 1 mm.
thalamocortical afferents labeled with Di-I and Schlaggar et al. (1993) have reported similar results from rats in which NMDA receptors were blocked in the developing cortex with APV and cortical organization was evaluated by staining for AChE. While it may difficult to relate the results of Chiaia et al. (1992) and those of Schlaggar et al. (1993) with those from the present study, it is worth pointing out the different effects of the manipulations employed in the three studies on cortical activity. Application of TTX should block most pre-and postsynaptic activity in the developing cortex (see Katz and Yuste, 199 1, for an exception to this generalization). Application of APV should attenuate all postsynaptic activation associated with glutamate and block that associated with activation of the NMDA receptor. In contrast, the main effect of 5-HT depletion during development should be enhancement of thalamocortical transmission (Shi et al., 1993) . Thus, administration of 5,7-DHT at birth should increase cortical activity while treatment with either TTX or APV should reduce it. This distinction is important since available data (Armstrong-James, 1975 ) suggest that the spontaneous activity level in the developing primary somatosensory cortex is low and stimulus-evoked responses are weak. It thus seems reasonable to suggest that blockade of activity in the developing somatosensory cortex of the rat has no effect on the morphometry of the vibrissa representation because activities levels during the period when this pattern is forming are already quite low. The potential of 5,7-DHT treatment to increase thalamocortical transmission and enhance cortical activity and its effect on the organization of thalamocortical afferents are consistent ,with the possibility that activity can influence normal thalamocortical development in the rat's somatosensory system, but perhaps only under unusual conditions such as those created by pharmacologic manipulations.
The present demonstration of modulation of the growth of a specific thalamocortical representation without any overall change in cortical mass appears inconsistent with the view regarding somatosensory cortical growth put forward by Riddle et al. (1992 Riddle et al. ( , 1993 . These investigators showed that different portions of the somatosensory cortical representation in rat, as demonstrated by CO staining, underwent considerable differential growth. In particular, the representation of the mystacial vibrissa follicles demonstrated a.very substantial increase in size while that shown for the dysgranular cortex was significantly smaller. Riddle et al. (1992) suggested that this differential growth might be the result of differing activity levels in these two regions. The results provided by Chiaia et al. (1992) Henderson et al. (1992) and Schlaggar et al. (1993) would suggest that activity that can be blocked by TTX may not be important for the differential postnatal growth of the representation of the vibrissa follicles. The present results extend these observations by showing that another manipulation that should have profound effects upon cortical activity reduces the size of the cortical representations ofindividual vibrissa follicles without changing the overall size of the cortical region devoted to the representation of the vibrissae.
